Meeting
2017 ASCO Annual Meeting
Whole exome sequencing (WES) of circulating tumor DNA (ctDNA) in patients with neuroendocrine prostate cancer (NEPC) informs tumor heterogeneity.
Authors
Himisha Beltran
Weill Cornell Medical College, New York, NY
Himisha Beltran , Alessandro Romanel , Nicola Casiraghi , Michael Sigouros , Matteo Benelli , Jenny Xiang , Francesca Demichelis
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Genitourinary (Prostate) Cancer
Track
Genitourinary Cancer—Prostate, Testicular, and Penile
Sub Track
Epidemiology/Outcomes
Citation
J Clin Oncol 35, 2017 (suppl; abstr 5011)
DOI
10.1200/JCO.2017.35.15_suppl.5011
Abstract #
5011
Poster Bd #
85
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Determinants of widespread metastases and of metastatic tropism in patients with prostate cancer: A genomic analysis of primary and metastatic tumors.
First Author: Edward Christopher Dee
Poster
2023 ASCO Genitourinary Cancers Symposium
Genomic alterations in patients with prostate cancer with liver metastases.
First Author: Crystal Casado
Poster
2023 ASCO Genitourinary Cancers Symposium
Evaluation of the aggressive variant prostate cancer molecular profile (AVPCm) in CLIA environments.
First Author: Paul Vincent Viscuse
Poster
2022 ASCO Annual Meeting
Genomic alterations and evolution in patients with prostate cancer with histologic evidence of neuroendocrine differentiation.
First Author: Ethan Barnett